company background image
YGEN logo

Yourgene Health AIM:YGEN Stock Report

Last Price

UK£0.0052

Market Cap

UK£16.4m

7D

1.0%

1Y

-90.9%

Updated

08 Sep, 2023

Data

Company Financials

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

YGEN Stock Overview

Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally.

YGEN fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Yourgene Health Plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Yourgene Health
Historical stock prices
Current Share PriceUK£0.0052
52 Week HighUK£0.057
52 Week LowUK£0.0019
Beta0.86
1 Month Change5.10%
3 Month Change139.53%
1 Year Change-90.89%
3 Year Change-97.04%
5 Year Change-96.25%
Change since IPO-96.78%

Recent News & Updates

Recent updates

Yourgene Health Plc (LON:YGEN) Shares Could Be 34% Above Their Intrinsic Value Estimate

Sep 22
Yourgene Health Plc (LON:YGEN) Shares Could Be 34% Above Their Intrinsic Value Estimate

Is There An Opportunity With Yourgene Health Plc's (LON:YGEN) 35% Undervaluation?

Apr 15
Is There An Opportunity With Yourgene Health Plc's (LON:YGEN) 35% Undervaluation?

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Yourgene Health Plc's (LON:YGEN) CEO For Now

Sep 22
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Yourgene Health Plc's (LON:YGEN) CEO For Now

Estimating The Intrinsic Value Of Yourgene Health Plc (LON:YGEN)

Aug 07
Estimating The Intrinsic Value Of Yourgene Health Plc (LON:YGEN)

Does This Valuation Of Yourgene Health Plc (LON:YGEN) Imply Investors Are Overpaying?

Feb 25
Does This Valuation Of Yourgene Health Plc (LON:YGEN) Imply Investors Are Overpaying?

What Did Yourgene Health's (LON:YGEN) CEO Take Home Last Year?

Jan 27
What Did Yourgene Health's (LON:YGEN) CEO Take Home Last Year?

What Kind Of Shareholders Hold The Majority In Yourgene Health Plc's (LON:YGEN) Shares?

Dec 22
What Kind Of Shareholders Hold The Majority In Yourgene Health Plc's (LON:YGEN) Shares?

Shareholder Returns

YGENGB Medical EquipmentGB Market
7D1.0%1.4%2.3%
1Y-90.9%3.6%2.7%

Return vs Industry: YGEN underperformed the UK Medical Equipment industry which returned -7.4% over the past year.

Return vs Market: YGEN underperformed the UK Market which returned -1.4% over the past year.

Price Volatility

Is YGEN's price volatile compared to industry and market?
YGEN volatility
YGEN Average Weekly Movement40.2%
Medical Equipment Industry Average Movement7.6%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.5%

Stable Share Price: YGEN's share price has been volatile over the past 3 months.

Volatility Over Time: YGEN's weekly volatility has increased from 25% to 40% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000253Lyn Reeshttps://www.yourgene-health.com

Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally. It develops in vitro diagnostic products, such as IONA Test, a non-invasive pre-natal test (NIPT) for Down’s syndrome, Edwards' syndrome, and Patau’s Syndrome in pregnant women; Cystic Fibrosis Screening tests; Rapid Aneuploidy Analysis, a confirmatory diagnostic test carried out after amniocentesi; and Recurrent Pregnancy Loss, a PCR assay for the routine diagnosis of the six most common chromosomes related to pregnancy loss, as well as DPYD genotyping products. The company also offers Ranger, a technology platform for sample size selection and enrichment; Elucigene DPYD assay, a PCR test to predict a patient’s response to a chemotherapy treatment; and Clarigene SARS-CoV-2 CE-IVD, a PCR assay used for routine COVID-19 testing.

Yourgene Health Plc Fundamentals Summary

How do Yourgene Health's earnings and revenue compare to its market cap?
YGEN fundamental statistics
Market capUK£16.45m
Earnings (TTM)-UK£8.17m
Revenue (TTM)UK£29.67m

0.6x

P/S Ratio

-2.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
YGEN income statement (TTM)
RevenueUK£29.67m
Cost of RevenueUK£13.21m
Gross ProfitUK£16.46m
Other ExpensesUK£24.63m
Earnings-UK£8.17m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.0026
Gross Margin55.48%
Net Profit Margin-27.55%
Debt/Equity Ratio15.7%

How did YGEN perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.